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Abstract 9 
Objective: To examine dynamic changes of ischial blood perfusion during sacral nerve root 10 
stimulation against surface functional electrical stimulation (FES). Methods: Fourteen adults 11 
with suprasacral complete spinal cord injury were recruited. The gluteal maximus was 12 
activated by surface FES or stimulating sacral nerve roots by functional magnetic stimulation 13 
(FMS) or a sacral anterior root stimulator implant (SARS). Ischial skin index of haemoglobin 14 
(IHB) and oxygenation (IOX) was measured. Results: Skin blood perfusion was significantly 15 
higher during FMS than the baseline (IHB 1.05±0.21 before vs. 1.08±0.02 during stimulation, 16 
P=0.03; IOX 0.18 ± 0.21 before vs. 0.46 ± 0.30, P=0.01 during stimulation, n=6). Similarly, 17 
when using the SARS implant, we also observed that blood perfusion significantly increased 18 
(IHB 1.01 ± 0.02 before vs. 1.07 ±0.02 during stimulation, P=0.003; IOX 0.79±0.81 before vs. 19 
2.2±1.21 during stimulation, P=0.03, n=6). However, there was no significant change of 20 
blood perfusion during surface FES. Among 4 participants who completed both the FMS and 21 
FES studies, the magnitude of increase in both parameters was significantly higher during 22 
FMS. Conclusion: This study demonstrates that using SARS implant is more efficient to 23 
activate gluteal muscles and confer better benefit on blood perfusion than applying traditional 24 
FES in SCI population.  25 
Key words:  electrical stimulation, pressure ulcer, sacral nerve roots, spinal cord injury, 26 
gluteal muscles, ischial tuberosity, blood perfusion.  27 
INTRODUCTION: 28 
Pressure ulcer is one of the most devastating conditions for people with Spinal Cord Injury 29 
(SCI)
1
.
 
 It is reported that up to 85% of adults with SCI will develop a pressure ulcer at some 30 
point during their lifetimes
1-5
, and 7-8% of those who develop pressure ulcers will die from 31 
related complications. 
6
 32 
According to National/ European Pressure Ulcer Advisory Panel guideline, pressure ulcer has 33 
been newly named as pressure injury, which is described as an area of localised injury to the 34 
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skin as a result of prolonged pressure alone, or pressure in combination with shearing forces.
7 
35 
It is typically categorised into four key stages depending on severity. The higher the grade is, 36 
the more severe the injury to the skin and underlying tissue will be. In stage one, the skin is 37 
not broken but is red or discoloured; the redness or change in colour does not fade within 38 
thirty minutes after pressure is removed. In stage two, the epidermis or topmost layer of the 39 
skin is broken, creating a shallow open sore and drainage may, or may not, be present. At 40 
stage three, the break in the skin extends through the dermis (second skin layer) into the 41 
subcutaneous and fat tissue and the wound is deeper than in stage two. In stage four, the 42 
breakdown extends into the muscle and can extend to the bone. At this stage, there is often a 43 
large amount of dead tissue and drainage. 44 
 45 
Following SCI, the interruption of spinal vasomotor pathways results in loss of vasomotor 46 
control over skeletal muscle and skin, which lowers the tone of vascular bed below the level 47 
of lesion. Impaired vascular patency causes vessels to be less able to withstand normal 48 
loading conditions. Concurrent with loss of capillary networks due to lost muscle bulk, the 49 
volume of blood in the tissues is reduced 
8-10
. Previous clinical studies have shown that tissue 50 
blood volume/perfusion was lower and tissue reperfusion was impaired in people with SCI in 51 
comparison with able-bodied subjects.
11-14 
For instance, Jan and colleagues measured sacral 52 
skin perfusion in 14 people with SCI and 14 healthy subjects during sitting
11
. They found skin 53 
perfusion declined more in people with SCI during constant sitting than able-bodied subjects.  54 
Furthermore, impaired vascular function in people with SCI has been reported by other 55 
studies.
12,13
 Makhsous and colleagues 12 measured transcutaneous partial pressures of oxygen 56 
and carbon dioxide of the buttock overlying the ischial tuberosity in 20 paraplegic individuals, 57 
20 tetraplegic individuals, and 20 able-bodied subjects. They found that recovery time during 58 
offloading was significantly longer in both paraplegic and tetraplegic participants in 59 
comparison with able-bodied individuals. As a result, people living with SCI have a higher 60 
risk of developing pressure ulcers than able-bodied individuals 61 
 62 
Once a pressure ulcer is formed, it is very difficult to achieve a full repair or it takes a 63 
particularly long period of time to heal for severe cases. In addition, those who suffer a 64 
pressure ulcer may be subjected to longer hospital stays, delayed rehabilitation and a 65 
significant loss of independence, which adds another burden to the psychological trauma of 66 
SCI, as well as the reduced quality of life.
15 
If a pressure ulcer is severe, it can lead to further 67 
disabilities, the need for surgical interventions and even fatal infections.
2,15
 In addition to the 68 
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detrimental personal effect, a pressure ulcer also represents a significant cost burden for 69 
health and social care systems. Although the exact cost of pressure ulcer management in 70 
people living with SCI is unknown in the United Kingdom, the average cost to treat one stage 71 
4 pressure ulcer is £14,108 per episode in the general population
16
. Given the significant 72 
personal consequences and serious health care burden, effective prevention of pressure ulcer 73 
is undoubtedly important for people living with SCI. 74 
Thus far, preventing pressure ulcer tends to focus on methods to reduce external pressure. 75 
These efforts range from using pressure-relieving devices, to patients performing ‘pressure 76 
relief’ manoeuvres themselves, such as frequent repositioning, ‘push-ups’ or ‘leaning forward 77 
17-20
.  However, these efforts are only partially effective at best in people living with SCI. 78 
Poor compliance from patients to carry out the frequent pressure relief activities together with 79 
intrinsic changes in the paralyzed individuals such as reduced vascular response to loading, 80 
reduced muscular tone and progressive loss of muscle bulk may contribute to the high 81 
incidence of pressure ulcer in this population
21-22
. Despite simple pressure relief methods 82 
providing benefits in reducing local pressure at bony prominences, such approaches were not 83 
aimed to prevent muscle atrophy or to improve muscular tone and tissue blood volume.  84 
Therefore, in conjunction to pressure relief strategies, alternative means of improving tissue 85 
health should be explored in this population for pressure ulcer prevention.
  
86 
In fact, activating paralyzed gluteal muscles to modify tissue blood circulation by using 87 
surface functional electrical stimulation (FES) has been explored in SCI for 30 years.
23-25
 For 88 
instance, back in the 1990s, Levine and colleagues
19
 examined ischial blood flow in six 89 
people with acute SCI during electrical stimulation of gluteus maximus. They found that skin 90 
blood flow increased during stimulation for all participants. Similarly, Gyawali and 91 
colleagues
24
 measured loaded gluteal tissue oxygenation during 7s or 13s of continuous 92 
electrical stimulation and 3s burst electrical stimulation of gluteus maximus using surface 93 
electrode in 17 patients with SCI who had  a mean age of 37 years. They reported that both 94 
continuous and burst electrical stimulation of gluteal muscles induced significant increases in 95 
tissue oxygenation assessed using T₂*-weighted magnetic resonance imaging techniques. 96 
However, the gluteus maximus has been difficult to stimulate by surface electrodes due to its 97 
greater mass covered by adipose tissue
26
. In addition, surface FES requires repeated 98 
application of large electrodes to the buttocks to stimulate the gluteal muscles, which can 99 
cause local dermatitis and excoriation. Importantly, muscles will eventually re-atrophy if 100 
stimulation is not continued
26
.  Therefore, surface FES has significant limitations if used for 101 
sustained benefit. Interestingly, implanted muscular electrical stimulation of gluteal muscles 102 
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has been shown to benefit seat pressure and tissue oxygenation in people living with SCI
26,27
. 103 
For instance, Wu and colleagues measured transcutaneous oxygen tension bilaterally over the 104 
ischia in seven patients living with SCI who had intramuscular electrodes implanted for 105 
combined trunk and gluteal muscles.  Trunk and gluteal stimulation was applied concurrently 106 
at 20-Hz frequency and 20-mA pulse amplitude for 5 minutes in their study. They reported 107 
that mean ischial transcutaneous oxygen tension increased during neuromuscular electrical 108 
stimulation and remained elevated after the intervention. 109 
Alternatively, sacral nerve roots stimulation has been reported to activate gluteal maximus in 110 
the able bodied and people with SCI.
28,29
  Sacral anterior root stimulator (SARS) implant is a 111 
well-established device for individuals with SCI to empty their bladder and bowel, where the 112 
electrodes are usually implanted intra- or extra-durally on bilateral S2, S3 or S4 sacral nerve 113 
roots. This implant has proven to be very cost effective and results in significant improvement 114 
in limiting urinary tract infections and increasing quality of life in people with SCI. Yet, such 115 
implant hasn’t been clinically applied for pressure ulcer prevention.  Indeed, our previous 116 
studies have demonstrated that sacral nerve roots stimulation can induce sufficient gluteal 117 
muscle contraction to reduce interface pressure and increase blood perfusion under the ischial 118 
tuberosity.
28,29 
For instance, FMS was first explored in able-bodies participants for pressure 119 
changes under the ischial tuberosity
28
. The primary objective of that study was to demonstrate 120 
the utility of FMS as an assessment tool, and map the optimal FMS stimulation parameters 121 
and the positioning of stimulating coil to be able to activate the S2 nerve root.  Secondly in 122 
order to test the feasibility and viability of stimulating the S2 nerve root using a well-123 
established implant for activating gluteal muscles, we stimulated the S2 nerve root alone in 124 
those patients who have a SARS implant for their daily bladder/bowl management. The 125 
results showed that S2 nerve root stimulation, either by FMS or using SARS implant, induced 126 
gluteus maximus contraction sufficient for significant reductions in ischial pressures during 127 
sitting in five able-bodied and six individuals with SCI who had a SARS implant respectively.  128 
 129 
Later, the FMS was further investigated in five patients with SCI for pressure changes under 130 
the ischial tuberosity
29
. In addition to ischial pressure measurement, skin blood perfusion 131 
changes were also simultaneously measured during the S2 nerve root stimulation in five 132 
patients during FMS and six patients with a SARS implant. Our results demonstrated that 133 
ischial pressures significantly decreased and cutaneous haemoglobin and oxygenation 134 
significantly increased during sacral nerve root stimulation via FMS or a SARS implant in all 135 
11 participants.  136 
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 137 
To compare the effect of S2 nerve root stimulation with traditional FES using surface 138 
electrodes, we then   reported another study
30
, in which the magnitude of pressure changes 139 
during S2 nerve root stimulation was compared with the pressure changes during traditional 140 
FES delivered by surface electrodes. Six patients with complete SCI were studied in each 141 
group. Interestingly, the results indicated that the magnitude of ischial pressure decrease was 142 
significantly greater during S2 nerve root stimulation via FMS or SARS implant than that 143 
obtained in participants who applied traditional FES.  144 
 145 
However, even S2 nerve root stimulation produce better benefits in reducing ischial pressure 146 
than traditional FES using surface electrodes. Skin blood perfusion has been suggested as a 147 
fundamental element for practical benefit in terms of pressure ulcer prevention. There was a 148 
consensus that the prolonged pressure loading sufficient to produce ischemia, cell 149 
deformation and reperfusion injury was identified as an important process of pressure ulcer 150 
formation
31,32
. Moreover, previous studies indicated that interface pressure alone does not 151 
provide complete information about the effectiveness of pressure relief
12
. So far, there are no 152 
published papers that directly compare the skin blood perfusion by sacral nerve root 153 
stimulation to traditional surface FES of gluteal muscles itself. 154 
 155 
Therefore, the objective of this study was to compare the magnitude of skin blood perfusion 156 
during gluteal maximus contraction through the stimulation of sacral nerve roots with the skin 157 
blood perfusion changes achieved using traditional surface FES in patients with SCI. 158 
 159 
 METHODS 160 
The project was approved by the National Health Service (NHS) research ethics committee, 161 
XXXX Hospital NHS Trust.  All participants gave their informed consent.  162 
Study design 163 
Three individual studies (FMS, SARS implant and surface FES) were conducted separately 164 
during a 12-month period. Each participant was invited to attend the research lab for 1.5-2 165 
hours. Before the experiment, all participants were asked to empty their bladder and bowel. 166 
Participants 167 
Subjects who had suprasacral complete SCI were aged between 18-65 years old and were 168 
recruited in FMS and surface ES studies.  All six participants who completed the FMS study 169 
were invited for surface FES study, four of them accepted the invitation. Individuals with an 170 
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electrode implanted on S2 nerve root in their SARS implant for bladder and/or bowel 171 
management were recruited for SARS implant study.  172 
Individuals who were pregnant or using a cardiac pacemaker were excluded for the FMS 173 
study; any subject with a current pressure ulcer over the gluteal region or a history of severe 174 
autonomic dysreflexia was excluded. 175 
Sacral nerve roots stimulation  176 
FMS study: 177 
FMS was delivered using a magnetic stimulator (MagPro, Dantec Medical A/S, and Denmark) 178 
with a large circular coil (120mm diameter, producing maximum field strength of 2 Tesla) 179 
placed over the sacrum area. To obtain a smooth tetanic fused contraction of the gluteal 180 
muscles, stimulation frequencies in the available range of 15-25pps for two seconds were 181 
utilized. Stimulation intensities were adjusted individually by starting from the lowest level 182 
from 30% in steps of 5% (stimulation strength is indicated as percentage of the maximum 183 
output) to the highest level of patients’ tolerance. The maximum level of intensity used was 184 
80%. To activate bilateral gluteus muscles, the coil position was placed at the sacrum midline, 185 
6cm below iliac crest for participants without sclerosis.  186 
A Fintech-Brindley SARS implant: 187 
Electrical stimulation was applied bilaterally through a Finetech-Brindley SARS implant 188 
(Finetech Medical Ltd, UK). A stimulation program was manually set up from an external 189 
control box. To avoid bladder/bowel activation, S3 & S4 stimulators were switched off. Only 190 
the S2 nerve root was stimulated. In order to obtain a smooth tetanic contraction, stimulation 191 
frequency of 20pps and duration of stimulation of 8-second were utilized. All patients were 192 
given lowest amplitude ‘1’ (highest amplitude was ‘3’) to avoid activating deeper muscles or 193 
organs such as bladder and bowel. The stimulation pulse width was adjusted individually by 194 
starting from the lowest pulse width of 8μs to the highest level of patients’ tolerance; the 195 
maximum pulse width used was 700 μs. 196 
Surface FES: 197 
Electrical stimulation was provided through large surface electrodes (PALS/Platinum, Model 198 
895240, Nidd Valley Medical Ltd, UK) using Stock Microstim2, a dual-channel 199 
neuromuscular stimulator. The specifications of the Microstim2 (v2) are: 1) stimulation 200 
frequencies are 20Hz and 40 Hz; 2) maximum pulse width is 330µs; 3) maximum output 201 
amplitude is 100mA; 4) the stimulation waveform is square with passive charge balancing. In 202 
order to be comparable with SARS, the stimulation frequency and duration of stimulation 203 
were set at 20 Hz and 8 seconds respectively. As per the stimulation amplitude, all 204 
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participants started from the lowest level of ‘1’ to highest level of patients’ tolerance, the 205 
maximum level of amplitude was level ‘9’. 206 
Ischial skin Haemoglobin and Oxygenation 207 
Tissue Reflectance Spectrometry (TRS) (MCS521 spectrometer, Carl Zeiss, Germany) in the 208 
visible spectrum was used to measure skin haemoglobin and oxygenation under ischial 209 
tuberosity.  The TRS uses the characteristic absorption of light by the constituents of skin to 210 
measure the various constituents present. The theory of tissue reflectance spectrometry is 211 
based on a simple anatomical model
33
. A thin flexible optical probe was designed, which does 212 
not cause loading artefact during sitting. This probe incorporated two plastic optical fibres (1 213 
mm diameter with 1 mm spacing) that were bonded in a Shore D60 flat flexible polyurethane 214 
sheath (Flexane 60L, Devcon Ltd, Ireland) for a transmission of incident and reflected light 215 
from the skin surface to the tissue reflectance spectrometry. The theoretical skin penetration 216 
depth was 500 um. 217 
Before each experiment, the TRS was always allowed to equilibrate for 30 minutes. The 218 
flexible thin flat optical probe was placed in the dark, then being placed onto a standard white 219 
surface to determine the reference light intensity. The sample rate for data acquisition of a 220 
full-spectrum was 2Hz with an integration time of 500ms and a cycle time of 0.5s. The 221 
absorption values for each wavelength increment of 1nm between 450 and 650nm were stored 222 
on a PC for offline processing. After data acquisition, the data were converted to ASCII text 223 
and exported to Microsoft Excel 2007. The indices of skin haemoglobin (IHB) and 224 
oxygenation (IOX) were calculated using modified version of a method by Feather et al
,29,33
. 225 
No melanin compensation was used. However, all participants were Caucasian with very little 226 
melanin over the skin covering the ischial tuberosity. Skin haemoglobin and oxygenation data 227 
were analysed by comparing IHB and IOX before and during stimulation when participants 228 
were sitting in the chair. During sitting, IHB would be close to 0. In order to prevent negative 229 
IOX, all IHB values were offset by a value of ‘1’. This was to make interpretation of IOX 230 
easier.  231 
Experiment setting:  232 
FMS and SARS studies: 233 
Prior to the experiment, participants were asked to rest 5-10 minutes and were given an 234 
introduction regarding the experiment. Following this, each participant was carefully 235 
transferred to a standard wheelchair with a standard foam cushion (high resilience foam, 236 
density 45kg/m3) and fitted arm and footrest. All participants had stabilized in a standard 237 
sitting position defined as: 1) back rest-to-seat angle of at least 80 degrees; 2) footrest 238 
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adjusted to keep the thighs parallel to the seat. The probe was then placed on the skin under 239 
the left/right ischial tuberosity with double-sided adhesive tape. The left or right ischial 240 
tuberosity was randomly selected. Spectral response of haemoglobins was continually 241 
monitored before and during maximal tolerated stimulation.  242 
Surface FES study: 243 
After they had entered the research lab and received an introduction to the experiment, each 244 
participant was helped to lie down on a standard hospital bed in a prone position. Two large 245 
rectangle electrodes (5cm×9cm) were placed onto each side of the gluteus maximus. The 246 
stimulating anodes were then placed bilaterally just below the posterior superior iliac crest. 247 
The participants were then carefully transferred to the study wheelchair. The skin probe 248 
placement and blood perfusion measurement was same as FMS and SARS studies. 249 
Statistical analysis 250 
Descriptive statistics were calculated using Excel 2007 and SPSS (IBM SPSS Statistics 19). 251 
All data were examined for normality using a Kolmogorov-Smirnov test. For comparison 252 
between before and during stimulation within same subjects, or comparison between FMS 253 
and surface FES within same subjects, paired sample t-test was used. Due to the small sample 254 
size of each study, non-parametric tests were also used to confirm the results from parametric 255 
tests where appropriate. Wilcoxon Signed-rank test was applied for comparison between 256 
before and during stimulation within same subjects.  P-values were two-tailed and differences 257 
were considered to be statistically significant for P-value less than 0.05. In addition to p value, 258 
Cohen’s d value was further reported to provide an estimate of the magnitude of differences 259 
associated with t-tests. Cohen's effect size d value of 0.2 or less represents a small effect or 260 
low practical significance, around 0.5 an intermediate effect and 0.8 or greater represents a 261 
large effect or high practical significance. 262 
 263 
RESULTS 264 
All participants who completed the studies tolerated stimulation well and no adverse events 265 
were reported. The skin areas where the electrodes and skin probe were placed were then 266 
inspected after each experiment. Baseline characteristics of all fourteen subjects are 267 
summarized in Table 1. 268 
FMS study 269 
Table 2 illustrates the FMS parameters in all 6 participants who completed FMS study. 270 
During optimal FMS, IHB and IOX increased in all 6 participants. As a group, IHB and IOX 271 
during stimulation were significantly higher than the baseline.  272 
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SARS study 273 
Optimal stimulation of S2 nerve root at frequency of 20 pps and amplitude of ‘1’ was utilised 274 
in the 6 individual participants. The pulse width varies among individual subjects ranging 275 
from 64 to 600μs. As a whole group, the average pulse width was 256μs. Table 3 276 
demonstrated optimal stimulation parameters in 6 participants   with a SARS Implant. 277 
For the whole group of six participants, IHB and IOX were significantly higher during 278 
stimulation than baseline.  Figure 1 demonstrates the value of IHB and IOX before and during 279 
SARS in six participants with a SARS implant. 280 
Surface FES study 281 
Out of six participants, five of them tolerated the highest level of amplitude of ‘9’ and one 282 
participant tolerated ‘7’. Table 4 demonstrates optimal FES parameters in six participants 283 
who had surface gluteal FES. During maximum tolerated stimulation, there was an increase 284 
of skin blood perfusion under the ischial tuberosity in all six participants. However, the 285 
increase was not statistically significant. Details of skin blood perfusion in the three studies 286 
are summarised in table 5. 287 
Comparison of blood perfusion during sacral nerve root stimulation and surface ES 288 
For those four participants who received both FMS and surface FES, the magnitude of 289 
increase in both IHB and IOX was significantly higher during FMS than surface FES (IHB 290 
mean difference=0.175±0.031, p=0.04, paired t-test; p=0.04, nonparametric Wilcoxon 291 
Signed-Rank test; IOX mean difference=0.133±0.265, p=0.03, paired t-test; p=0.04, 292 
nonparametric Wilcoxon Signed-Rank test). 293 
 294 
DISCUSSION  295 
The primary objective of this study was to compare dynamic effects of ischial blood perfusion 296 
changes during sacral nerve root stimulations and gluteal muscle stimulation using traditional 297 
electrodes. In addition, this study investigated the feasibility of the customized flexible probe 298 
for real-time measuring of blood perfusion during sitting in those individuals    living with 299 
SCI.  The results from the study demonstrate that S2 nerve root stimulation through a SARS 300 
implant can induce gluteus muscle contractions sufficient to achieve a significant increase in 301 
skin blood perfusion during sitting. By using traditional surface electrodes to activate gluteal 302 
muscles, there was no significant change in blood perfusion during surface FES.  303 
Indeed, the inconsistency of findings in blood flow during stimulating gluteal muscles using 304 
surface electrodes has been previously reported in SCI.
24,25,20,
. While some of those studies 305 
reported a significant increase in regional tissue oxygenation or blood flow during the 306 
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stimulation, other studies reported an insignificant increase of tissue oxygenation. For 307 
instance, Smit and colleagues
25
 applied electrical stimulation to gluteal and hamstring 308 
muscles through surface electrodes and measured tissue blood flow and oxygenation in 12 309 
male patients with SCI aged 26–52 years old using a commercial instrument (Oxygen To See 310 
device) with a rigid probe.  The device adopted a combination of reflection spectroscopy and 311 
laser Doppler technique. They reported that there were no significant changes of mean blood 312 
flow and oxygenation during electrical stimulation as compared with the rest, although there 313 
was a significant difference in peak blood flow during electrical stimulation as compared with 314 
the rest. Conversely, Levine and colleagues examined ischial blood flow in six acute patients 315 
with SCI during electrical stimulation of gluteus maximus
23
. They found that skin blood flow 316 
increased during stimulation for all participants. 317 
While the exact mechanism of improving local tissue oxygenation and blood flow during the 318 
ES remains unclear, increased blood perfusion may result from muscle contraction allowing 319 
higher oxygen delivery rates and metabolite removal, or neuronal excitation may contribute to 320 
the increase of blood perfusion.  Alternatively, a dynamic ‘pressure relief’ caused by gluteus 321 
muscle contractions and/or pelvic tilt, which dilates the micro-vessels underlying the ischial 322 
skin, may be partly attributable. While previous studies investigated the interface pressure and 323 
tissue oxygenation or blood flow simultaneously during gluteal electrical stimulation e
24-27
, 324 
these studies, in general, had a small sample size without control groups.   None of those 325 
studies proved the hypothesis that electrical stimulation induced muscle activation would 326 
directly increase blood flow and oxygenation.  Increasing sample size and recording more 327 
subjects’ characteristic factors in the future studies may help understand the findings of this 328 
study.  329 
In theory, all muscles consist of a number of motor units and the fibres belonging to a motor 330 
unit are dispersed and interlink amongst fibres of other units. A motor unit normally consists 331 
of one motor neuron and all of the muscle fibres it stimulates.  The muscle fibres belonging to 332 
one motor unit can be spread throughout a part, or most of the entire muscle, depending on 333 
the number of fibres and size of the muscle. When a motor neuron is activated, all of the 334 
muscle fibres innervated by the motor neuron are stimulated and contracted. The activation of 335 
single motor neuron results in a weak distributed muscle contraction (twitch contraction). In 336 
contrast, the activation of more motor neurons will result in more muscle fibres being 337 
activated, and therefore a stronger muscle contraction (tetanic contraction) was produced.   338 
The higher the recruitment of motor unit, the stronger the muscle contraction will be. The 339 
activation of more motor neurons will result in more muscle fibers being activated, and 340 
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therefore a stronger muscle contraction
34
. In comparison, between sacral nerve root 341 
stimulation versus traditional surface FES of gluteal muscles, the larger numbers of motor 342 
neurones recruitment in sacral nerve roots stimulation may produce stronger contraction than 343 
surface FES. Therefore it can activate gluteus muscles more efficiently. Sacral nerve root 344 
stimulation can efficiently activate all motor neurons that innervate gluteal maximus, whereas 345 
surface FES of gluteus maximus maybe limited by the size of electrodes and the depth of 346 
electrical signal to reach the muscle motor points. 347 
It is worth noting that although the index of haemoglobin and oxygenation was increased 348 
during the S2 nerve root stimulations in this study, it is difficult to compare the magnitude of 349 
changes with other studies in the literature. A variety of stimulation parameters used 350 
alongside different modalities employed blood perfusion measurement among each study was 351 
identified.  In terms of blood perfusion measurement techniques, previous studies that 352 
investigated acute effect of electrical stimulation on blood circulation utilized various 353 
modalities, which include laser Doppler flowmetry, transcutaneous oximeters and near-354 
infrared spectroscopy 
24-27, 35
.  So far, regardless of the modalities adopted, the dermal probes 355 
were rigid, which can potentially increase local pressure during sitting, or have movement 356 
artefact. In the present study, tissue reflectance spectrometry was utilised, which is an optical 357 
technique and offers the distinct advantages of being non-invasive with no artefact of 358 
movement and real-time recording. More importantly, a customised thin flexible dermal 359 
probe was applied for the real-time blood perfusion measurement during sitting.  The inter-360 
fiber cross talk was tested and coupling was not found. A flexible dermal probe such as this 361 
has potential for future monitoring studies during sitting, and examining key factors in 362 
pressure ulcer development. 363 
The long-term goal of such research is to reverse gluteus muscle atrophy, build up muscle 364 
bulk and improve tissue viability by stimulating gluteus maximus through a SARS implant in 365 
people with supra-sacral spinal lesions. Traditional surface FES is a well-established 366 
technique to activate paralysed muscles including gluteal maximus in SCI. Yet it is not 367 
particularly practical or efficient in the long term or for sustained effect in SCI. It would be 368 
better to deliver gluteal electrical stimulation through implanted electrodes, and better still if 369 
this could be achieved using a durable SARS stimulator such as Fintech SARS. The results 370 
from current study indicate that sacral nerve root stimulation via implanted electrodes can 371 
induce sufficient gluteus maximus contraction to significantly increase cutaneous 372 
haemoglobin and oxygenation during sitting. Compare to our previous study
30
, which we 373 
reported sacral nerve root stimulation confer better modulation of sitting pressure than 374 
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traditional surface FES, the conclusions from this study are that stimulation via an implanted 375 
SARS may be useful for gluteus muscle bulking and improving vascularisation for preventing 376 
ischial pressure injuries. In addition to restoring bladder control with a SARS implant, 377 
implanted S2 nerve-root electrodes may also provide frequent, convenient, and sufficient 378 
stimulation of gluteus muscles and has the potential to improve tissue heath in SCI population.  379 
Study limitations 380 
One of the limitations of our study was the small sample size along with the pilot study 381 
design.  Unmatched age, body mass index, gluteal mass and level and duration of injuries 382 
were not addressed.  However, four participants who completed FMS were recruited and 383 
agreed to participate FES studies, which allowed us to perform a paired sample t test and 384 
Wilcoxon signed-rank nonparametric test in the four subjects.  385 
Another limitation was the use of a single skin probe to measure blood perfusion in the study. 386 
While non-invasive tissue reflectance spectrometry incorporated with customised probe 387 
provides real-time data, using only one skin probe with a limited skin area restricted us to 388 
compare blood perfusion changes on both sides within each subject. Developing a dual probe 389 
to measure skin blood perfusion bilaterally with a high sampling frequency, deep penetration 390 
and multiple skin area measurements should be considered in future studies.   391 
 Finally, the stimulation was only applied in a single burst to investigate the dynamic effect of 392 
sacral nerve stimulations on gluteus maximus. Due to the limitations of FMS over-heating 393 
and being ill-defined, it is impossible to apply more cycles of stimulation in the protocol 394 
presented in this study. Nevertheless, our study provides the basis of designing future 395 
rigorous studies by investigating more cycles of stimulation over longer periods, and 396 
modifying electrical stimulation parameters such as frequency, pulse width and durations, 397 
alongside using the customised thin, flexible skin probe for real-time blood perfusion 398 
measurement.  399 
CONCLUSION  400 
Gluteal muscle activity via S2 nerve root can induce sufficient gluteus maximus contraction 401 
in SCI to promote blood flow. Skin blood perfusion was significantly increased during sacral 402 
nerve root stimulation, but the change was not significant during traditional FES using surface 403 
electrodes.  SARS implant may be more convenient and more efficient in activating gluteal 404 
muscles compared to traditional surface FES. This study confirmed that the S2 stimulation 405 
through an implant is viable and has potential for gluteal pressure ulcer prevention in SCI.  406 
However, in order to justify adding S2 stimulating electrodes in those patients who have 407 
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opted for an implantable SARS for their bladder and bowel management, future well designed, 408 
large sample studies are warranted to confirm current findings.  409 
 410 
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           Table 1 Demographic characteristic of all participants in three studies 
 
 
 
 
 
 
 
 
 
             FMS=Functional magnetic stimulation; SARS=Sacral anterior root simulator; ES=Electrical stimulation 
  *Four participants completed both FMS and Surface ES study 
 
 
 
 
 
 
 
            
   
 
Variables FMS (n=6)* SARS (n=6) Surface ES (n=6)* 
Age (mean ± SD) 
Gender (F/M) 
BMI (mean ± SD) 
Level of injury 
Years of  injury (mean ± SD) 
 
40.33±9.69 
 
1/5 
 
23.78±2.64 
 
C5/6-T10/11 
 
8.17±6.11 
 
44.50±10.07 
 
1/5 
 
24.77±6.06 
 
T3 –T10/11 
 
14.33±6.47 
 
41.50±4.97 
 
1/5 
 
25.65±5.09 
 
T4/5-T10/11 
 
8.33±5.05 
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 Table 2 Optimal stimulation parameters in 6 participants who had functional magnetic stimulation 
 
 
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Participant Duration 
Optimal 
 
Frequency 
maximal tolerated 
 
Intensity 
Vertical Optimal 
 
coil location 
Optimal  coil 
 
location for 
  (Hz) (%) (distance to iliac bilateral 
    crest) response 
1 2 25 60% 60mm midline 
2 2 20 50% 60mm 20mm to right 
3 2 20 60% 60mm      midline 
4 2 20 65% 60mm      midline 
5 2 20 80% 60mm 20mm to  left 
6 2 20 60% 60mm midline 
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Table 3 Optimal stimulation parameters in six participants who used a SARS Implant. 
 
 
 
 
 
 
 
 
 
  
Table 4  Optimal stimulation parameters in six participants who used surface electrodes 
 
 
 
 
 
 
 
Patients Duration Frequency(Hz) Amplitude Optimal Pulse Width 
1 8s 20 1 256 μsec 
2 8s 20 1 128 μsec 
3 8s 20 1 600 μsec 
4 8s 20 1 256 μsec 
5 8s 20 1 128 μsec 
6 8s 20 1 512 μsec 
Patients 
1 
Duration 
8s 
Frequency(Hz) 
20 
Amplitude 
8 
Optimal Pulse Width 
330μsec 
2 8s 20 7 330 μsec 
3 8s 20 8 330 μsec 
4 8s 20 9 330 μsec 
5 8s 20 9 330 μsec 
6 8s 20 8 330 μsec 
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Table 5  Skin blood perfusion before and during stimulations in the three studies 
P value<0.05;
   
***Cohen’s effect size value d>0.8 suggested a high practical significance;  
** Cohen’s effect size value 0.5 <d<0.8 suggested a medium practical significance;  
* Cohen’s effect size value d<0.5 suggested a low practical significance 
SD=Standard deviation 
 
 
 
 
 
 
 
 
Variables FMS (n=6) SARS (n=6) Surface ES (n=6) 
Skin blood content    
     Baseline (mean ± SD) 1.05±0.21 1.01 ± 0.02 1.05 ± 0.01 
     Stimulation (mean ± SD) 1.08±0.02 1.07 ±0.02 1.06 ±0.01 
     Paired sample t-test 
          t value (degree of  freedom) 
         P value 
 
t(5)=2.9 
 0.03 
 
t(5)=5.5 
0.003   
 
t(5)=2.3 
0.07 
        Cohen’s effect size (d)   0.2* 6.0*** 0.4* 
Skin blood oxygenation     
     Baseline (mean ± SD) 0.18 ± 0.21 0.79±0.81 0.56±0.39 
     Stimulation (mean ± SD 0.46 ± 0.30 2.2±1.27 0.86±0.41 
     Paired sample t-test 
          t value (degree of  freedom) 
         P value 
 
t(5)=3.6 
 0.01 
 
t(5)=3.0 
0.03   
 
t(5)=1.8 
0.12 (NS) 
        Cohen’s effect size (d)   1.0*** 3.4*** 0.4* 
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Figure 1  The value of  Index of haemoglobin and Oxygenation  before and during electrical 
stimulation in six participants using a sacral anterior root implant 
 
(a)                                                            (b)
 
